Terms: = Bone cancer AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC
26 results:
1. Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands.
Santi I; Vellekoop H; M Versteegh M; A Huygens S; Dinjens WNM; Mölken MR
Mol Diagn Ther; 2024 May; 28(3):319-328. PubMed ID: 38616205
[TBL] [Abstract] [Full Text] [Related]
2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
3. Kinase fusion positive intra-osseous spindle cell tumors: A series of eight cases with review of the literature.
Suurmeijer AJH; Xu B; Torrence D; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23205. PubMed ID: 37782551
[TBL] [Abstract] [Full Text] [Related]
4. Marginal resection as a potential curative treatment option of infantile fibrosarcoma with good response after chemotherapy: A case report of an ETV6-ntrk3 positive infantile fibrosacroma of the distal tibia.
Weber M; von Kunow F; Hillmann A
Medicine (Baltimore); 2023 Jul; 102(27):e34194. PubMed ID: 37417635
[TBL] [Abstract] [Full Text] [Related]
5. Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation.
Zhang ML; Sabatino ME; Castillo CF; Mattia AR; Chebib I
Diagn Cytopathol; 2023 May; 51(5):E164-E169. PubMed ID: 36762822
[TBL] [Abstract] [Full Text] [Related]
6. Primary NTRK-rearranged spindle cell neoplasm of bone harboring an HMBOX1::ntrk3 gene fusion.
Wang Z; Wang J
Genes Chromosomes Cancer; 2023 Aug; 62(8):477-482. PubMed ID: 36740981
[TBL] [Abstract] [Full Text] [Related]
7. A novel TMTC2-ntrk3 fusion in undifferentiated high-grade pleomorphic sarcoma.
Bai C; Zhang L; Wang Y; You X; Ju Y; Sun T; Fan Z
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2933-2937. PubMed ID: 35933643
[TBL] [Abstract] [Full Text] [Related]
8.
Siozopoulou V; Marcq E; De Winne K; Norga K; Schmitz G; Duwel V; Delvenne P; Smits E; Pauwels P
Pathol Oncol Res; 2022; 28():1610423. PubMed ID: 35645621
[TBL] [Abstract] [Full Text] [Related]
9. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
Baranov E; Winsnes K; O'Brien M; Voss SD; Church AJ; Janeway KA; DuBois SG; Davis JL; Al-Ibraheemi A
Histopathology; 2022 Aug; 81(2):215-227. PubMed ID: 35543076
[TBL] [Abstract] [Full Text] [Related]
10. NTRK Fusions Detection in Paediatric Sarcomas to Expand the Morphological Spectrum and Clinical Relevance of Selected Entities.
Nozzoli F; Lazar AJ; Castiglione F; Campanacci DA; Beltrami G; De Logu F; Caporalini C; Massi D; Roviello G
Pathol Oncol Res; 2022; 28():1610237. PubMed ID: 35295613
[TBL] [Abstract] [Full Text] [Related]
11. Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with ntrk3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.
Capela de Matos RR; Othman M; Ferreira GM; Monteso K; de Souza MT; Rouxinol M; Melo JB; Carreira IM; Abdelhay E; Liehr T; Ribeiro RC; Silva M
Cancer Genet; 2022 Apr; 262-263():16-22. PubMed ID: 34974289
[TBL] [Abstract] [Full Text] [Related]
12. Expanding the Molecular Genetic Spectrum of bone and Soft Tissue Fibrosarcomas: An Institutional Experience.
Leckey BD; John I; Wald A; Naous R
Int J Surg Pathol; 2022 Apr; 30(2):145-150. PubMed ID: 34382874
[No Abstract] [Full Text] [Related]
13. A Case of Papillary Thyroid Carcinoma and Kostmann Syndrome: A Genomic Theranostic Approach for Comprehensive Treatment.
Han S; Ehrhardt J; Shukla S; Elkbuli A; Nikiforov YE; Gulec SA
Am J Case Rep; 2019 Jul; 20():1027-1034. PubMed ID: 31308356
[TBL] [Abstract] [Full Text] [Related]
14. (Mammary Analogue) Secretory Carcinoma of the Nasal Cavity: Report of a Rare Case with p63 and DOG1 Expression and Uncommon Exon 4-Exon 14 ETV6-ntrk3 Fusion Diagnosed with Next Generation Sequencing.
Wu B; Loh TKS; Vanecek T; Michal M; Petersson F
Head Neck Pathol; 2020 Jun; 14(2):542-549. PubMed ID: 31273600
[TBL] [Abstract] [Full Text] [Related]
15. New fusion sarcomas: histopathology and clinical significance of selected entities.
Miettinen M; Felisiak-Golabek A; Luiña Contreras A; Glod J; Kaplan RN; Killian JK; Lasota J
Hum Pathol; 2019 Apr; 86():57-65. PubMed ID: 30633925
[TBL] [Abstract] [Full Text] [Related]
16. Novel ntrk3 Fusions in Fibrosarcomas of Adults.
Yamazaki F; Nakatani F; Asano N; Wakai S; Sekimizu M; Mitani S; Kubo T; Kawai A; Ichikawa H; Yoshida A
Am J Surg Pathol; 2019 Apr; 43(4):523-530. PubMed ID: 30520818
[TBL] [Abstract] [Full Text] [Related]
17. Mammary Analog Secretory Carcinoma of the Nasal Cavity: Characterization of 2 Cases and Their Distinction From Other Low-grade Sinonasal Adenocarcinomas.
Baneckova M; Agaimy A; Andreasen S; Vanecek T; Steiner P; Slouka D; Svoboda T; Miesbauerova M; Michal M; Skálová A
Am J Surg Pathol; 2018 Jun; 42(6):735-743. PubMed ID: 29543674
[TBL] [Abstract] [Full Text] [Related]
18. Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in
Smith KM; Fagan PC; Pomari E; Germano G; Frasson C; Walsh C; Silverman I; Bonvini P; Li G
Mol Cancer Ther; 2018 Feb; 17(2):455-463. PubMed ID: 29237803
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
[TBL] [Abstract] [Full Text] [Related]
20. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.
Luo W; Lindley SW; Lindley PH; Krempl GA; Seethala RR; Fung KM
Int J Clin Exp Pathol; 2014; 7(12):9008-22. PubMed ID: 25674280
[TBL] [Abstract] [Full Text] [Related]
[Next]
